“Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated With Pembrolizumab”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, pp. 2006-10, https://doi.org/10.25251/skin.8.6.17.